Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.

MLA

Jitprapaikulsan, Jiraporn, et al. “Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.” Ophthalmology, vol. 125, no. 10, Oct. 2018, pp. 1628–37. EBSCOhost, https://doi.org/10.1016/j.ophtha.2018.03.041.

APA

Jitprapaikulsan, J., Chen, J. J., Flanagan, E. P., Tobin, W. O., Fryer, J. P., Weinshenker, B. G., McKeon, A., Lennon, V. A., Leavitt, J. A., Tillema, J.-M., Lucchinetti, C., Keegan, B. M., Kantarci, O., Khanna, C., Jenkins, S. M., Spears, G. M., Sagan, J., & Pittock, S. J. (2018). Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis. Ophthalmology, 125(10), 1628–1637. https://doi.org/10.1016/j.ophtha.2018.03.041

Chicago

Jitprapaikulsan, Jiraporn, John J Chen, Eoin P Flanagan, W Oliver Tobin, Jim P Fryer, Brian G Weinshenker, Andrew McKeon, et al. 2018. “Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.” Ophthalmology 125 (10): 1628–37. doi:10.1016/j.ophtha.2018.03.041.